Top 10 Pharmaceutical Contract Manufacturing Companies, Recommended list

Many drug makers work with outside partners to help produce their medicines. These companies handle tough jobs like scaling up production, meeting safety rules, and managing new technologies. Their work keeps research moving and helps ensure treatments reach patients on time.

Lonza

Kuruluş Yılı: 1897

Ana Ürünler:

• Mammalian biologics and monoclonal antibodies.
• Small molecule APIs and intermediates.
• Highly potent APIs (HPAPIs).
• Bioconjugates and antibody-drug conjugates (ADCs).
• Cell and gene therapies.
• Microbial manufacturing services.
• Drug substance and drug product manufacturing.
• Capsules and health ingredients.

Lonza is based in Basel, Switzerland, and it’s a huge, old firm that makes drugs for other businesses. You could say it’s one of the giants in the medicine world.

This company has been around for a very long time, starting way back in 1897. But funnily enough, it didn’t start with medicine. It first got into making electricity and chemicals before finally jumping into biotech.

Lonza was actually one of the very first to rent out its factory space to others, starting in 1982. This gave it a massive head start with decades of know-how that other folks just don’t have. They really have a long history of getting things done right.

With about 19,000 people on the payroll, the firm runs more than 30 sites on five continents, so its business is all over the map. Having big operations in Europe, North America, and Asia lets them work right alongside their clients.

The work is split into different groups that handle all sorts of projects. They make everything from complex biologic drugs to simpler chemical ones. They also work on brand-new stuff like cell and gene therapies and even have special clean rooms for handling powerful ingredients that need extra caution.

Thermo Fisher Scientific (Pharma Services)

Kuruluş Yılı: 2006

Ana Ürünler:

• Small molecule drug development and manufacturing.
• Large molecule biologics development and manufacturing.
• Viral vectors and gene therapy manufacturing.
• Sterile injectable manufacturing.
• Clinical trial materials and logistics.
• Formulation development services.
• Drug substance and drug product manufacturing.
• Advanced therapy medicinal products.
• Continuous manufacturing technologies.

The drug services part of Thermo Fisher Scientific is in Waltham, Massachusetts, and it goes by the name Patheon. The company as we know it today came together in 2006. That’s when two big firms, Thermo Electron and Fisher Scientific, decided to team up.

A really big deal for their drug-making group was buying Patheon in 2017 for an incredible $7.2 billion. Patheon was already a well-known name that had been around since 1974. That purchase brought in a ton of smart people and ready-to-go production sites.

So now, the company runs a huge network of sites, mostly in North America and Europe, with some spots in Asia and Australia, too. This setup means they can help out all kinds of customers, from tiny startups with a fresh idea to the biggest drug companies on Earth.

They offer a whole menu of services that can take a new medicine from a simple concept to a product ready for the market. They can handle simple chemical pills and much more complex biologic drugs.

Thermo Fisher uses modern tricks like continuous manufacturing. Think of it like a non-stop assembly line for medicine, which makes everything faster and better.

And being part of the bigger Thermo Fisher company is a great perk. It means the drug-making side can easily get the best science tools and lab supplies to help them do their jobs.

Catalent

Kuruluş Yılı: 2007

Ana Ürünler:

• Softgel manufacturing and development.
• Oral solid dosage forms.
• Sterile injectable manufacturing.
• Biologics drug substance and drug product.
• Cell and gene therapy manufacturing.
• Vaccine development and manufacturing.
• Clinical trial materials and packaging.
• Drug delivery technologies including Zydis.
• Advanced therapy medicinal products.
• Bioconjugates and antibody-drug conjugates.

Catalent’s home base is in Somerset, New Jersey, and it’s a world leader in making things for medicine and health companies. Even though it officially started in 2007, its story really begins in 1933 with the invention of the softgel pill, which is still a big deal for them.

This company is famous for finding smart ways to get medicine into the body. For instance, they created Zydis, a pill that melts on your tongue in just a few seconds, which is amazing for anyone who has trouble swallowing. They also have a system called GPEx that helps create biologic drugs.

Catalent is a pretty large operation, with around 19,000 employees at over 50 sites around the globe. The business is basically split in two. One side works on things like injectable drugs and new cell therapies, while the other side is all about pills and their famous softgels.

In a huge deal, the firm was bought by Novo Holdings in 2024. As part of that sale, some of its sites were handed over to help pump out the massive amounts of popular GLP-1 drugs that people use for diabetes and weight loss.

Samsung Biologics

Kuruluş Yılı: 2011

Ana Ürünler:

• Contract development organization (CDO) services.
• Contract manufacturing organization (CMO) services.
• Monoclonal antibody manufacturing.
• Bispecific antibody development.
• Cell line development services.
• Process development and optimization.
• Analytical method development.
• Drug substance and drug product manufacturing.
• Drug product manufacturing.
• Biosafety testing services.

Based in Incheon, South Korea, Samsung Biologics has grown at a jaw-dropping pace to become the world’s biggest contract maker of biologic drugs.

It was started in 2011 by the famous Samsung Group. It was a planned jump into the very important field of biopharma.

So how on earth did it get so big, so fast? Even though it’s a newer kid on the block, the company’s growth has been just wild. The secret was that they just started building massive, high-tech production plants one after another.

From 2011 to 2023, they put up four gigantic plants. This building boom gave them more room to make biologics than any other single contract company in the world.

Their main campus is in Songdo, South Korea, but they’ve also opened offices in the United States. This helps the team stay connected with their American clients.

The firm offers a full list of services for making biologic drugs. This covers the whole process, from creating the living cells that act as tiny drug factories to making the final medicine on a giant scale.

Their hard work has paid off. Get this—today, 17 of the world’s top 20 drug companies hire Samsung Biologics to make their products, which just goes to show how much trust they’ve built.

WuXi AppTec

Kuruluş Yılı: 2000

Ana Ürünler:

• Small molecule drug discovery services.
• Contract research and development services.
• API development and manufacturing.
• Drug formulation development.
• Preclinical testing services.
• Clinical research services.
• Bioanalytical services.
• Cell and gene therapy CDMO services.
• Medical device testing services.
• Chemistry manufacturing services.

WuXi AppTec’s home is in Shanghai, China. You can think of it like a giant toolbox that offers almost any research, development, or production service you can imagine to the health industry.

The company was started back in 2000 by Dr. Ge Li. He began with just a few people in a small lab but had a huge dream: to create a place that could help make any drug for any sickness.

It was one of the very first Chinese firms to offer these kinds of services to drug makers around the globe. A huge step forward came in 2007 when it was listed on the New York Stock Exchange. That was a big deal for a Chinese drug company and helped it get the cash to get even bigger.

Jump to today, and WuXi AppTec is a global giant. It has more than 30,000 workers at over 30 locations in Asia, Europe, and North America.

It helps over 6,000 customers from all corners of the world. This lets it work with everyone, from small startups to the biggest drug companies.

The company uses a model that it calls “CRDMO.” Really, it’s just a fancy way of saying it’s a one-stop shop that can help a client with every single step of making a drug.

This style is super helpful and saves customers a lot of headaches. Plus, the company is known for its quality work. Its sites have been approved by the big regulators in the U.S., Europe, and other places, so clients can rest easy.

WuXi Biologics

Kuruluş Yılı: 2010

Ana Ürünler:

• Monoclonal antibody development and manufacturing.
• Bispecific antibody services.
• Cell line development services.
• Process development and optimization.
• Upstream and downstream process development.
• Analytical and quality control services.
• Small-scale non-GMP manufacturing.
• cGMP biologics manufacturing.
• Drug substance manufacturing.
• Drug product services.

With its main office in Wuxi, China, WuXi Biologics is a top name for services for biologic drugs. It was started in 2010 as a part of WuXi AppTec to focus just on medicines made from living cells, like antibodies.

This firm grew incredibly fast, putting up world-class sites and boosting its ability to make drugs. It now has some of the biggest setups for making biologics among all contract makers. One neat thing they did was build the world’s largest site using giant, disposable bags for growing cells instead of huge metal tanks, which is a very modern and flexible method.

A key event was when it went public on the Hong Kong Stock Exchange in 2017. This move raised around $510 million, which it poured right back into growing its sites and tech. That cash helped lock in its spot at the top.

WuXi Biologics offers a full package that covers the whole process of making a biologic drug, from the first spark of an idea to the final product. The firm helps over 1,000 clients in more than 30 countries.

Asymchem

Kuruluş Yılı: 1999

Ana Ürünler:

• Small molecule APIs and intermediates.
• Carbapenems.
• Glycans.
• Peptides
• Oligonucleotides.
• Process development services.
• Analytical testing services.
• Custom synthesis services.
• Highly potent compound manufacturing.
• Contract development and manufacturing services.

Asymchem is a global CDMO in Tianjin, China, that makes drugs for medicine and biotech firms. A man named Dr. Hao Hong founded it in 1999, and he still runs the show today.

But the story really begins a little earlier, in 1995, when Dr. Hong opened a single lab in North Carolina. His goal was to find better, greener, and cheaper ways to make new medicines.

Asymchem hit some big targets early in its life. It started its first big production run in 2001 and, most importantly, passed its first U.S. FDA inspection in 2007. That approval was the golden ticket because it meant it could work with companies from anywhere in the world.

In 2018, the firm went public on the Shenzhen Stock Exchange, which helped it get money for its global growth. A big piece of that growth was opening its first European production site in the UK in 2024.

Asymchem now runs eight production sites around the world. It gives its clients a full range of services, from helping design a production plan to making the final drug for sale. It also invests a lot of its own money back into research to make sure it’s always using the latest tech.

Porton Pharma Solutions

Kuruluş Yılı: 2005

Ana Ürünler:

• Small molecule CDMO services.
• TIDES (peptides and oligonucleotides).
• Biologics development and manufacturing.
• Antibody-drug conjugates (ADCs).
• Antibody-oligonucleotide conjugates (AOCs).
• Peptide-drug conjugates (PDCs).
• Advanced therapy medicinal products (ATMPs).
• Flow chemistry services.
• Biocatalysis services.
• Crystallization services.
• Preparative chromatography.

Porton Pharma Solutions is in Chongqing, China, and is a well-known global CDMO. It helps companies through every single part of the drug-making process.

The company was founded in 2005 by three people with a big mission. They wanted to “Enable the Public’s Early Access to Good Medicines.” So they started with a production site in Chongqing and a research lab in Chengdu.

A big move for the company was getting listed on the Shenzhen Stock Exchange in 2014. That gave it the cash it needed to start growing all over the world.

A key part of its plan was buying other companies. For instance, it scooped up J-Star Research Inc. in the USA in 2017. This helped it get a firm grip in key markets outside of China.

Porton’s buildings have all passed checks from major health watchdogs like the U.S. FDA and European agencies. Passing its first FDA check in 2013 with a perfect score was a great sign of its high standards.

The company has kept right on growing. New sites in the USA, Slovenia, and Shanghai all opened up in 2023.

It now has over 4,200 employees and a fantastic reputation. It has finished thousands of projects for more than 1,300 customers.

Porton works on many different types of drugs, from regular pills to more complex biologics and new tech. The company just keeps expanding under its CEO, Oliver Ju.

Pharmaron

Kuruluş Yılı: 2004

Ana Ürünler:

• Small molecule drug discovery services.
• Biologics development and manufacturing.
• Cell and gene therapy services.
• Contract research organization (CRO) services.
• Contract development and manufacturing (CDMO) services.
• Antibody discovery and protein science.
• Process development services.
• Analytical and quality control services.
• Clinical development services.
• Manufacturing services for APIs and drug products.

Pharmaron is based in Beijing, China, and it’s a major service company for the health sciences. It does a mix of research work and production work. Basically, they can help you invent a drug, and then they can help you make it.

Şirket kuruldu 2004 by a group of people who wanted to offer great, affordable services to drug makers.

It grew pretty fast in its first few years. It built up its labs and started working with clients from all over the world.

A big step was going public on the Shenzhen Stock Exchange in 2015. This step gave them the money for even more growth.

In 2022, Pharmaron made another smart move by buying SCIREX, a U.S.-based company. This purchase enhanced the clinical research services and gave them a larger presence in North America.

Today, the company is a global business with over 20,000 employees. It has sites in China, the United States, and the United Kingdom.

Pharmaron offers a comprehensive, all-in-one service that encompasses the entire drug development process. This means it can help a client with everything from the first idea to the final product. It works with small pills, biologics, and even super advanced cell and gene therapies.

Recipharm

Kuruluş Yılı: 1995

Ana Ürünler:

• Oral solid dosage manufacturing.
• Sterile fill and finish services.
• Biologics manufacturing.
• Injectable products manufacturing.
• Inhalation products and devices.
• Lyophilization services.
• Blow-fill-seal (BFS) technology.
• Clinical trial material manufacturing.
• Pharmaceutical development services.
• API development and manufacturing.

Recipharm is a top global CDMO with its main office in Stockholm, Sweden. The company has over 5,200 workers and does business in more than 100 markets.

It has a pretty neat origin story. It got started in 1995 when two managers, Thomas Eldered and Lars Backsell, bought a pill-making factory from a bigger company.

At first, their new company, which they called “Recip,” just kept making things for the old owner. But they also started offering their services to other companies on the side.

Then, in 2007, they made a huge change. The company sold off its own brand of products to focus completely on being a contract maker for others. This was a bold move, but it let Recipharm use that money to buy other sites and grow across Europe, the US, and India.

Recipharm went public in 2014. But it was later bought in 2021 by an investment firm and taken off the stock market. This was done to give the company more freedom to think about its long-term future.

The company now runs 17 sites in ten different countries. It makes hundreds of different products every year and works with many of the top ten drug companies in the world.

Çözüm

The companies behind today’s drug manufacturing scene do more than just make products. They keep research moving, fill supply gaps, and help new treatments reach the market safely. Their mix of experience and innovation has made them a quiet but vital part of modern healthcare.

Telif Hakkı Uyarısı: 

Finetech Group'un önceden açık yazılı onayı olmadan bu web sitesindeki herhangi bir içeriği çoğaltamaz, değiştiremez, yayınlayamaz, görüntüleyemez, iletemez veya herhangi bir şekilde istismar edemezsiniz veya bu tür içeriği herhangi bir veritabanı oluşturmak için kullanamazsınız. İçeriği kullanma izni için lütfen iletişime geçin: info@pharmamachinecn.com

Yasal Uyarı:

Bu makalede yer alan bilgiler yalnızca genel bilgilendirme amaçlıdır. Şirket, herhangi bir bilginin doğruluğunu, güncelliğini veya eksiksizliğini garanti etmez ve Şirket, bu makalenin içeriğindeki hatalar veya eksiklikler için hiçbir sorumluluk kabul etmez.